RedHill Biopharma Ltd.
RDHL
$1.02
-$0.01-0.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.13M | -6.72M | -9.31M | -8.79M | -8.27M |
| Total Depreciation and Amortization | 168.00K | 268.50K | 369.00K | 494.00K | 619.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -428.00K | 824.00K | 1.64M | -848.50K | -3.34M |
| Change in Net Operating Assets | -622.00K | -542.50K | -463.00K | 795.00K | 2.05M |
| Cash from Operations | -5.02M | -6.17M | -7.77M | -8.35M | -8.94M |
| Capital Expenditure | -4.00K | -8.00K | -12.00K | -10.50K | -9.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -8.00K | -12.00K | -10.50K | -9.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -189.00K | -300.00K | -411.00K | -523.50K | -636.00K |
| Issuance of Common Stock | 3.45M | 3.45M | 3.45M | 5.86M | 8.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -104.50K | 265.00K | 290.50K | 316.00K |
| Cash from Financing | 3.26M | 3.04M | 3.30M | 5.62M | 7.94M |
| Foreign Exchange rate Adjustments | 9.00K | 16.50K | 24.00K | 16.50K | 9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.75M | -3.12M | -4.45M | -2.72M | -992.00K |